Literature DB >> 24366663

Organ-specific phenotypic and functional features of NK cells in humans.

Richa Sharma1, Asmita Das.   

Abstract

Natural killer (NK) cells kill virus-infected and tumor target cells without prior sensitization. Each NK cell expresses a multitude of activating and inhibitory receptors, and the interplay of signals determines the outcome of NK cell activity. NK cell-mediated cytolysis of target cell involves polarized degranulation at effector-target interface. Peripheral blood NK cell constitutes about 10% of lymphocytes, and approximately 90% of peripheral blood NK cells are CD56(dim)CD16(+); however, there is a distinct subset of NK cells, CD56(bright)CD16(-), expressed by certain lymphoid organs which are able to produce large amounts of cytokines including interferon-γ, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor, but the cytotoxicity is attained only on their prolonged activation. In this review, we discuss the accumulated data on distinct phenotypes of NK cells in human uterus, liver, intestine, skin, and lung and also attempt to correlate their phenotype with corresponding activity and functions, with significant stress on the role of NK cells in pathology in the specific organs. Our detailed understanding of altered NK cell activity in different organs and their inherent cytotoxic activity against tumor target cells will help us design better immunotherapeutic strategies in NK cell-mediated cancer therapies.

Entities:  

Mesh:

Year:  2014        PMID: 24366663     DOI: 10.1007/s12026-013-8477-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  69 in total

1.  GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.

Authors:  Lei Xu; Shahinoor Begum; Jeremy D Hearn; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

2.  Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.

Authors:  Hun Sik Kim; Asmita Das; Catharina C Gross; Yenan T Bryceson; Eric O Long
Journal:  Immunity       Date:  2010-02-26       Impact factor: 31.745

3.  Lytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cells.

Authors:  Asmita Das; Eric O Long
Journal:  J Immunol       Date:  2010-09-10       Impact factor: 5.422

4.  Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.

Authors:  Masahiro Ohira; Seigo Nishida; Panagiotis Tryphonopoulos; Akin Tekin; Gennaro Selvaggi; Jang Moon; David Levi; Camillo Ricordi; Kohei Ishiyama; Yuka Tanaka; Hideki Ohdan; Andreas G Tzakis
Journal:  Cell Transplant       Date:  2012       Impact factor: 4.064

5.  Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines.

Authors:  Niels Halama; Monika Braun; Christoph Kahlert; Anna Spille; Christian Quack; Nuh Rahbari; Moritz Koch; Jürgen Weitz; Matthias Kloor; Inka Zoernig; Peter Schirmacher; Karsten Brand; Niels Grabe; Christine S Falk
Journal:  Clin Cancer Res       Date:  2011-02-15       Impact factor: 12.531

6.  Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

Authors:  Tetsuro Takayama; Nobuhiko Kamada; Hiroshi Chinen; Susumu Okamoto; Mina T Kitazume; Jonathan Chang; Yumi Matuzaki; Sadafumi Suzuki; Akira Sugita; Kazutaka Koganei; Tadakazu Hisamatsu; Takanori Kanai; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2010-06-01       Impact factor: 22.682

7.  Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.

Authors:  Paolo Carrega; Gaetana Pezzino; Paola Queirolo; Irene Bonaccorsi; Michela Falco; Giuseppe Vita; Daniela Pende; Aldo Misefari; Alessandro Moretta; Maria Cristina Mingari; Lorenzo Moretta; Guido Ferlazzo
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

8.  CD27 defines phenotypically and functionally different human NK cell subsets.

Authors:  Mireille T M Vossen; Mourad Matmati; Kirsten M L Hertoghs; Paul A Baars; Mi-Ran Gent; Georges Leclercq; Jörg Hamann; Taco W Kuijpers; René A W van Lier
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

9.  KIR2DL4 (CD158d): An activation receptor for HLA-G.

Authors:  Sumati Rajagopalan; Eric O Long
Journal:  Front Immunol       Date:  2012-08-20       Impact factor: 7.561

10.  NK-cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by parvovirus infection of target cells.

Authors:  Rauf Bhat; Jean Rommelaere
Journal:  BMC Cancer       Date:  2013-07-31       Impact factor: 4.430

View more
  13 in total

Review 1.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

2.  A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity.

Authors:  Yanlan Wang; Jiayu Liu; Haitao Pan; Jieyu Xing; Xiaoqiong Wu; Qing Li; Zhong Wang
Journal:  J Vis Exp       Date:  2018-07-12       Impact factor: 1.355

3.  Alloimmune activation promotes anti-cancer cytotoxicity after rat liver transplantation.

Authors:  Stéphanie Lacotte; Graziano Oldani; Florence Slits; Lorenzo A Orci; Laura Rubbia-Brandt; Philippe Morel; Gilles Mentha; Christian Toso
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

Review 4.  Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor.

Authors:  Silvia Pesce; Lorenzo Moretta; Alessandro Moretta; Emanuela Marcenaro
Journal:  Front Immunol       Date:  2016-10-07       Impact factor: 7.561

5.  NK and NKT-Like Cells in Patients with Recurrent Furunculosis.

Authors:  Danuta Nowicka; Ewelina Grywalska; Elżbieta Fitas; Michał Mielnik; Jacek Roliński
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-12-13       Impact factor: 4.291

Review 6.  NK cells in mucosal defense against infection.

Authors:  Daria Ivanova; Ryan Krempels; Jennyfer Ryfe; Kaitlyn Weitzman; David Stephenson; Jason P Gigley
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

Review 7.  Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis.

Authors:  InCheul Jeung; Keunyoung Cheon; Mee-Ran Kim
Journal:  Biomed Res Int       Date:  2016-05-12       Impact factor: 3.411

8.  Chemokine Receptor Expression on Normal Blood CD56(+) NK-Cells Elucidates Cell Partners That Comigrate during the Innate and Adaptive Immune Responses and Identifies a Transitional NK-Cell Population.

Authors:  Margarida Lima; Magdalena Leander; Marlene Santos; Ana Helena Santos; Catarina Lau; Maria Luís Queirós; Marta Gonçalves; Sónia Fonseca; João Moura; Maria Dos Anjos Teixeira; Alberto Orfao
Journal:  J Immunol Res       Date:  2015-10-12       Impact factor: 4.818

9.  Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?

Authors:  Xudong Zhang; Xiaorui Fu; Meng Dong; Zhenzhen Yang; Shaoxuan Wu; Mijing Ma; Zhaoming Li; Xinhua Wang; Ling Li; Xin Li; Zhenchang Sun; Yu Chang; Feifei Nan; Jiaqin Yan; Yun Mao; Mingzhi Zhang; Qingjiang Chen
Journal:  Cancer Cell Int       Date:  2018-10-01       Impact factor: 5.722

Review 10.  NK Cells as Potential Targets for Immunotherapy in Endometriosis.

Authors:  Aneta Ścieżyńska; Michał Komorowski; Marta Soszyńska; Jacek Malejczyk
Journal:  J Clin Med       Date:  2019-09-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.